High-risk type-2 diabetes mellitus patients, without prior ischemic events, have normal blood platelet functionality profiles: a cross-sectional study (Q35736714)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 June 2015

Language	Label	Description	Also known as
English	High-risk type-2 diabetes mellitus patients, without prior ischemic events, have normal blood platelet functionality profiles: a cross-sectional study	scientific article published on 12 June 2015

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

High-risk type-2 diabetes mellitus patients, without prior ischemic events, have normal blood platelet functionality profiles: a cross-sectional study (English)

1 reference

Europe PubMed Central

10 August 2017

author name string

Gadi Shlomai

1

1 reference

Europe PubMed Central

10 August 2017

Tal Haran-Appel

2

1 reference

Europe PubMed Central

10 August 2017

Tal Sella

3

1 reference

Europe PubMed Central

10 August 2017

Yoni Grossman

4

1 reference

Europe PubMed Central

10 August 2017

Hagit Hauschner

5

1 reference

Europe PubMed Central

10 August 2017

Nurit Rosenberg

6

1 reference

Europe PubMed Central

10 August 2017

Ehud Grossman

7

1 reference

Europe PubMed Central

10 August 2017

language of work or name

0 references

publication date

12 June 2015

1 reference

Europe PubMed Central

10 August 2017

Cardiovascular Diabetology

1 reference

Europe PubMed Central

10 August 2017

14

1 reference

Europe PubMed Central

10 August 2017

80

1 reference

Europe PubMed Central

10 August 2017

copyright license

Creative Commons Attribution 4.0 International

12 June 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1186/s12933-015-0244-x

0 references

Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

PLA1A2 platelet polymorphism predicts mortality in prediabetic subjects of the population based KORA S4-Cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Standards of medical care in diabetes--2014

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Platelet function profiles in patients with diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Correlation between mean platelet volume and fasting plasma glucose levels in prediabetic and normoglycemic individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Aspirin for primary prevention of cardiovascular events in people with diabetes, etc.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Oxidative stress and platelets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Platelet activation and atherothrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Atherothrombosis and high-risk plaque: part I: evolving concepts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Platelet activation in type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Antiplatelet agents in the prevention of diabetic vascular complications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Randomised trial of prophylactic daily aspirin in British male doctors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Final report on the aspirin component of the ongoing Physicians' Health Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

12 July 2018

Aspirin Half Maximal Inhibitory Concentration Value on Platelet Cyclooxygenase1 in Severe Type-2 Diabetes Mellitus is not Significantly Different from that of Healthy Individuals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

25 September 2018

Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: methodological considerations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

25 September 2018

Effects of improved metabolic control on platelet reactivity in patients with type 2 diabetes mellitus following coronary angioplasty.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

25 September 2018

Effects of increased concentrations of glucose on platelet reactivity in healthy subjects and in patients with and without diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

25 September 2018

Glycated low density lipoproteins modify platelet properties: a compositional and functional study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

25 September 2018

Platelet antioxidant enzymes in insulin-dependent diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

25 September 2018

Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

25 September 2018

Large Platelets Circulate in an Activated State in Diabetes Mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

25 September 2018

The basis examination of leukocyte-platelet aggregates with CD45 gating as a novel platelet activation marker

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4465477

25 September 2018

The platelet insulin receptor: Detection, partial characterization, and search for a function

1 reference

https://api.crossref.org/works/10.1186%2FS12933-015-0244-X

21 January 2018

Effect of intensive glycemic control on platelet reactivity in patients with long-standing uncontrolled diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26068309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Res

1 reference

https://pubmed.ncbi.nlm.nih.gov/26068309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glycation accelerates the oxidation of low density lipoprotein by copper ions

1 reference

https://pubmed.ncbi.nlm.nih.gov/26068309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet reactivity characterized prospectively: a determinant of outcome 90 days after percutaneous coronary intervention

1 reference

https://pubmed.ncbi.nlm.nih.gov/26068309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased platelet membrane fluidity due to glycation or acetylation of membrane proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/26068309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Membrane lipid fluidity of blood platelets: a common denominator that underlies the opposing actions of various agents that affect platelet activation in whole blood

1 reference

https://pubmed.ncbi.nlm.nih.gov/26068309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/26068309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/26068309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and men

1 reference

https://pubmed.ncbi.nlm.nih.gov/26068309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/26068309

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S12933-015-0244-X

1 reference

Europe PubMed Central

10 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35736714&oldid=1856723835"